The term "umbilical cord matrix" is used both for the native Wharton's jelly tissue inside the cord and for processed allograft formats derived from it. Formats vary by supplier and may include a ready-to-use suspension or gel, or a lyophilized (freeze-dried) powder, depending on the processing method used to turn recovered tissue into a distributable product.
Processing for these products is commonly described by suppliers as following FDA regulation and AATB and AABB guidelines, a description of practice rather than a certification. Each format carries its own storage requirement: cryopreserved formats need a cold chain and careful handling on dry ice, while lyophilized formats are described by the supplier as shelf-stable under normal conditions.
Before purchasing, request the product insert describing the exact processing method, a lot-specific certificate of analysis, and storage and handling instructions matched to that specific format. Confirm this documentation directly for each supplier rather than assuming two suppliers' "umbilical cord matrix" products are equivalent, since composition and processing can differ meaningfully between them.
Because "umbilical cord matrix" covers several distinct formats and processing methods, buyers need format-specific documentation rather than treating the category name as one interchangeable product.